Therapeutic Approaches to Increase the Survival Rate of Cancer Patients in the Younger and Older Population
- PMID: 38062658
- DOI: 10.2174/0118746098241507231127114248
Therapeutic Approaches to Increase the Survival Rate of Cancer Patients in the Younger and Older Population
Abstract
Various developments have been observed in the treatment of cancer patients, such as higher survival rates and better treatment outcomes. However, expecting similar outcomes in older patients remains a challenge. The main reason for this conclusion is the exclusion of older people from clinical trials for cancer drugs, as well as other factors, such as comorbidity, side effects, age-related frailties and their willingness to undergo multiple treatments. However, the discovery of new techniques and drug combinations has led to a significant improvement in the survival of the elderly population after the onset of the disease. On the other hand, cancer treatments have not become more complex for the younger population when compared to the older population, as the younger population tends to respond well to treatment trials and their physiological conditions are stable in response to treatments. In summary, this review correlates recent cancer treatment strategies and the corresponding responses and survival outcomes of older and younger patients.
Keywords: Cancer; ageing; cell therapy; chemotherapy; radiotherapy; survival rate..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Aspects of survival from colorectal cancer in Denmark.Dan Med J. 2012 Apr;59(4):B4428. Dan Med J. 2012. PMID: 22459726
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068 Review.
-
The role of myelopoietic growth factors in managing cancer in the elderly.Drugs. 2002;62 Suppl 1:47-63. doi: 10.2165/00003495-200262001-00004. Drugs. 2002. PMID: 12479594 Review.
-
Effect of Age on Clinical Outcomes in Phase 1 Trial Participants.Cancer Control. 2015 Apr;22(2):235-41. doi: 10.1177/107327481502200217. Cancer Control. 2015. PMID: 26068771
-
The consequence of undertreating breast cancer in the elderly.J Am Coll Surg. 2001 Jun;192(6):698-707. doi: 10.1016/s1072-7515(01)00832-8. J Am Coll Surg. 2001. PMID: 11400963
References
-
- Age and Cancer Risk Available from: https://www.cancer.gov/about-cancer/causes-prevention/risk/age 2021
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources